Analyst Sees Dendreon's (DNDN) Efforts to Boost Provenge Demand Bearing Fruit in Q4; Shares Jump

Article Stock Quotes (2) Comments (0)

Shares of Dendreon (Nasdaq: DNDN) spiked more than 4 percent higher in morning trade Thursday following some reassuring comments from BofA analyst Rachel McMinn. The stock is now trading around $7.79.

McMinn believes the recent changes implemented by Dendreon's management to boost demand will "bear fruit" sometime during the fourth quarter. The analyst noted the company's warning of some noise over the next two quarters for Provenge amid management changes and new data on J&J's (NYSE: JNJ) Zytiga at the American Society of Clinical Oncology meeting this month. Dendreon will offer an update on new account additions following the meeting, specifically on any negative effects, McMinn said.

Visit our Analyst Ratings page to stay up-to-date on all the marking-moving analyst calls on Dendreon.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: MKM Partners Downgrades Alkermes (ALKS) to Sell
• Wedbush Downgrades salesforce.com (CRM) to Neutral
• Hewlett-Packard (HPQ) Q2 Performance Wins Praise on Wall Street; Jefferies Raises to Hold

Create E-mail Alert Related Categories

Analyst Comments

Related Entities

Bank of America

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?